At a glance
ClinicalIndex Comparison RecordN/ACompleted· 208 enrolled
Drug / intervention
not interventional studyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung Medical University Chung-Ho Memorial Hospital·observational·Posted Oct 27, 2015·Updated Feb 27, 2019
In Brief
An observational study evaluating not interventional study for Hepatocellular Carcinoma. Completed, enrolled 208 participants across 2 sites.
Detailed Summary
The aim of this project is to investigate whether the proliferative speeds of cultured cells using our method can be integrated into Barcelona Clinic Liver Cancer (BCLC) staging classification for the possibility of personalized treatment and prediction the outcomes in hepatocellular carcinoma (HCC) patients.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHepatocellular Carcinoma
CountriesTaiwan
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartOct 2014
First PostedOct 2015
Primary CompletionJul 2018
TodayJul 2026
First PostedOct 27, 2015
Enrollment StartOct 1, 2014
Primary CompletionJul 31, 2018
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 10.7 years ago
Interventions
not interventional studyother